Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $6.45 USD
Change Today -0.055 / -0.85%
Volume 1.4M
As of 11:51 AM 05/6/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John Peter McLaughlin J.D.

Chief Executive Officer, President, Director and Member of Litigation Committee, PDL BioPharma, Inc.
AgeTotal Calculated CompensationThis person is connected to 25 board members in 3 different organizations across 5 different industries.

See Board Relationships
62$4,070,042
As of Fiscal Year 2014

Background*

Mr. John Peter McLaughlin, J.D., has been the Chief Executive Officer and President at PDL BioPharma Inc. since December 18, 2008. Mr. McLaughlin was a Co-Founder of Peak Surgical Inc. Mr. McLaughlin served as an Acting Chief Financial Officer of PDL BioPharma, Inc. from February 14, 2012 to May 13, 2013 and its Acting Chief Accounting Officer from February 13, 2013 to May 13, 2013. He served as the Chief Executive Officer of Corgentech Inc., since January 2000. Mr. ...

Read Full Background

Corporate Headquarters*

932 Southwood Boulevard
Incline Village, Nevada 89451

United States

Phone: 775-832-8500
Fax: 775-832-8501

Board Members Memberships*

Co-Founder and Director
2000-N/A
Former Chief Executive Officer, Director, Member of Stock Award Committee and Member of Special Committee
2000-2008
Former Chief Executive Officer and Director
2000-N/A
Former Chairman of the Board, Chairman of Compensation Committee and Member of Governance and Nominations Committee
2007-Present
Director, Member of Audit Committee and Member of Compensation Committee
2008-Present
Chief Executive Officer, President, Director and Member of Litigation Committee
2012-2014
Former Director
2014-Present
Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee

Education*

BA
University of Notre Dame
JD
Catholic University of America

Other Affiliations*

Annual Compensation*

Salary$716,108
Total Annual Compensation$716,108

Stock Options*

Restricted Stock Awards$984,510
All Other Compensation$10,000
Exercisable Options15,085
Total Number of Options15,085

Total Compensation*

Total Annual Cash Compensation$3,085,532
Total Short Term Compensation$716,108
Other Long Term Compensation$994,510
Total Calculated Compensation$4,070,042
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PDLI:US $6.45 USD -0.055

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John W. Varian Chief Executive Officer and Director
XOMA Corporation
$569.5K
Michael S. O. Oredsson B.Int’l Bus Admin (Lund)Chief Executive Officer and President
BioInvent International AB
kr735.0K
Jan G. J. van de Winkel Ph.D.Co-Founder, Chief Executive Officer and President
Genmab A/S
kr11.0M
Tim Van Hauwermeiren MSc, EMBAChief Executive Officer and Executive Director
arGEN-X N.V
€256.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PDL BIOPHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.